Skip to main content
. 2020 Dec 11;10(1):189–199. doi: 10.1007/s40119-020-00208-0

Table 2.

Comparison of patients’ P2Y12 reaction units (PRU) and the percentage of high on-treatment platelet reactivity before and after empagliflozin 25 mg

Mean platelet reaction units (PRU) Lower 95% confidence interval (CI) Upper 95% confidence interval (CI) p value High on-treatment platelet reactivity (HPR) % p value
Baseline 217.25 180.60 253.90 < 0.030 75 < 0.060
Empagliflozin 187.35 155.38 219.32 50